Bohn E, Autenrieth I B
Institute for Hygiene and Microbiology, Wurzburg University, Germany.
J Immunol. 1996 Feb 15;156(4):1458-68.
Although Yersinia enterocolitica is extracellularly located in infected tissues, a specific T cell response is required to overcome infection. Recent work implicated that in contrast to Yersinia-susceptible BALB/c mice, C57BL/6 mice are Yersinia resistant due to the rapid development of a Yersinia-specific Th1 T cell response. This study focused on the role of IL-12 in Y. enterocolitica infections in both mouse strains. We found that C57BL/6 and BALB/c mice produced comparable quantities of IL-12 mRNA after Y. enterocolitica infection. Likewise, Yersinia-infected bone marrow macrophages from both mouse strains produced equal quantities of IL-12. Administration of neutralizing anti-IL-12 Abs abrogated resistance against yersiniae in either strain. In addition, administration of rIL-12 rendered BALB/c mice resistant to yersiniae, while this treatment was toxic to C57BL/6 mice. IL-12-mediated protection was partially dependent on IFN-gamma. Spleen cells from both strains of mice produced Yersinia-triggered IFN-gamma in an IL-12-dependent manner, although those from BALB/c mice produced 10-fold lesser quantities. Administration of rIL-12 in vivo increased Yersinia-induced IFN-gamma production by BALB/c spleen cells in vitro, but decreased IFN-gamma production by spleen cells from C57BL/6 mice. IL-10 was antagonistic to IL-12 only in BALB/c mice and inhibited Yersinia-triggered IFN-gamma production. In vivo depletion experiments revealed that IL-12 accounts for Yersinia-induced IFN-gamma production by both NK cells and CD4+ T cells, the latter of which are an essential source of IFN-gamma r while NK cell-derived IFN-gamma production can be compensated by other cells. In contrast to that in the spleen, IL-12 plays a minor role in protection against yersiniae in Peyer's patches after orogastric infection. In summary, our data suggest that IL-12 is rapidly induced by Y. enterocolitica infection and required for IFN-gamma production by NK cells as well by CD4+ T cells. Although BALB/c and C57BL/6 mice produced comparable quantities of IL-12, IFN-gamma production, and thus resistance to yersiniae, can be increased by exogenous IL-12 only in BALB/c, not in C57BL/6, mice.
尽管小肠结肠炎耶尔森菌在感染组织中位于细胞外,但仍需要特定的T细胞反应来克服感染。最近的研究表明,与易感染耶尔森菌的BALB/c小鼠相比,C57BL/6小鼠对耶尔森菌具有抗性,这是由于耶尔森菌特异性Th1 T细胞反应的快速发展。本研究聚焦于IL-12在这两种小鼠品系小肠结肠炎耶尔森菌感染中的作用。我们发现,小肠结肠炎耶尔森菌感染后,C57BL/6和BALB/c小鼠产生的IL-12 mRNA量相当。同样,来自这两种小鼠品系的经耶尔森菌感染的骨髓巨噬细胞产生的IL-12量相等。给予中和性抗IL-12抗体可消除任一品系小鼠对耶尔森菌的抗性。此外,给予重组IL-12可使BALB/c小鼠对耶尔森菌产生抗性,而这种处理对C57BL/6小鼠有毒性。IL-12介导的保护作用部分依赖于IFN-γ。两种品系小鼠的脾细胞均以IL-12依赖的方式产生耶尔森菌触发的IFN-γ,尽管BALB/c小鼠的脾细胞产生的量少10倍。体内给予重组IL-12可增加体外BALB/c脾细胞由耶尔森菌诱导的IFN-γ产生,但可降低C57BL/6小鼠脾细胞的IFN-γ产生。IL-10仅在BALB/c小鼠中对IL-12起拮抗作用,并抑制耶尔森菌触发的IFN-γ产生。体内耗竭实验表明,IL-12是由NK细胞和CD4+ T细胞产生的耶尔森菌诱导IFN-γ的原因,其中后者是IFN-γr的重要来源,而NK细胞来源的IFN-γ产生可由其他细胞代偿。与在脾脏中的情况相反,IL-12在经口胃感染后对派伊尔结中耶尔森菌感染的保护作用较小。总之,我们的数据表明,小肠结肠炎耶尔森菌感染可迅速诱导IL-12产生,且IL-12是NK细胞以及CD4+ T细胞产生IFN-γ所必需的。尽管BALB/c和C57BL/6小鼠产生的IL-12量相当,但只有BALB/c小鼠而非C57BL/6小鼠可通过外源性IL-12增加IFN-γ产生,从而增强对耶尔森菌的抗性。